Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Complex comprising a PSMA-targeting compound linked to a lead or thorium radionuclide

Complex comprising a PSMA-targeting compound linked to a lead or thorium radionuclide

US Patent 12297218 · Granted May 13, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Production of highly purified 212Pb2025
Production of highly purified 212PB2025
Production of highly purified 212PB2025
Production of highly purified 212Pb2024
Preparation of 212Pb labeled monoclonal antibodies2022
Method for upregulating antigen expression2020
Radiopharmaceutical solutions with advantageous properties2019
Lead and thorium compounds2019
Monoclonal antibody and derivatives2017
Radiotherapeutic particles and suspensions2017
Radiopharmaceutical solutions with advantageous properties2016
Radioimunoconjugates and uses thereof2016